Gestational diabetes - on broadening the diagnosis
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Gestational diabetes mellitus, which is defined as the onset or first recognition of carbohydrate intolerance during pregnancy, is estimated to affect between 6 and 9% of pregnant women in the United States.1,2 Associated perinatal outcomes include excessive fetal growth that can lead to maternal or fetal birth trauma, hypertensive disorders of pregnancy, and neonatal hypoglycemia.3 Trials have shown that the treatment of women with gestational diabetes can reduce many of these immediate outcomes,4,5 and these trials led the U.S. Preventive Services Task Force to conclude that there is a net benefit to routinely screening for and treating gestational diabetes.6 Despite . . .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cons to the one-step approach: There is insufficient evidence to justify the increase in health care costs of broadening the diagnosis by implementing a one-step approach [87].”
From Gestational Diabetes Mellitus: Diagnostic Approaches and Maternal-Offspring Complications (2022) · cites this paper as [87]
In the citing paper
“However, the problems which we have described make it difficult to support the conclusion that “.the perinatal benefits of the diagnosis of gestational diabetes with use of the IADPSG single-step approach appear to be insufficient to justify the associated patient and health care costs of broadening the diagnosis” as put forth in the accompanying editorial.5”
From One-step or 2-step testing for gestational diabetes: which is better? (2021) · cites this paper as [5]
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122
Self-citationMetzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002501 · Cited by 1,820
A pragmatic, randomized clinical trial of gestational diabetes screening
Hillier, T. A., Pedula, K. L., Ogasawara, K. K., Vesco, K. K., Oshiro, C. E. S., Lubarsky, S. L., & Van Marter, J. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2026028 · Cited by 270
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2905 · Cited by 223
Werner, E. F., Pettker, C. M., Zuckerwise, L., Reel, M., Funai, E. F., Henderson, J., & Thung, S. F. (2012) · Diabetes Care · doi:10.2337/dc11-1643 · Cited by 182
(2013) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31829c3e64 · Cited by 124
Cited by
A Clinical Update on Gestational Diabetes Mellitus
Sweeting, A., Wong, J., Murphy, H. R., & Ross, G. P. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac003 · Cited by 928
Gestational Diabetes Mellitus: Diagnostic Approaches and Maternal-Offspring Complications
Moon, J. H., & Jang, H. C. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0335 · Cited by 377
“Cons to the one-step approach: There is insufficient evidence to justify the increase in health care costs of broadening the diagnosis by implementing a one-step approach [87].”
BackgroundGestational diabetes: Implications for fetal growth, intervention timing, and treatment options
Mirabelli, M., CHIEFARI, E. D., Tocci, V., Greco, E. A., FOTI, D. P., & Brunetti, A. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.06.003 · Cited by 75
One-step or 2-step testing for gestational diabetes: which is better?
Coustan, D. R., Dyer, A. R., & Metzger, B. E. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.05.009 · Cited by 40
Screening and diagnosis of gestational diabetes
White, S. L., Ayman, G., Bakhai, C., Hillier, T. A., & Magee, L. A. (2023) · BMJ · doi:10.1136/bmj-2022-071920 · Cited by 30
Metadata
- Authors
- Casey, B.
- Affiliations
- University of Alabama at Birmingham (US)
- Corresponding author
- Casey, Brian
- ORCID
- Casey, Brian
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-03-11
- Volume
- 384
- Issue
- 10
- Pages
- 965-966
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3135191926
- Cited by
- 23
- References
- 9
- Citations by year
- 2024: 4 · 2023: 5 · 2022: 8 · 2021: 6
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- gestational diabetes mellitus, diagnostic criteria, carbohydrate intolerance, pregnancy, perinatal outcomes, macrosomia, hypertensive disorders of pregnancy, neonatal hypoglycemia, screening, treatment
- MeSH terms
- Female, Glucose Tolerance Test, Humans, Mass Screening, Pregnancy, Diabetes, Gestational
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gestational diabetes - on broadening the diagnosis. https://app.cochat.ai/papers/10.1056/nejme2100902
- The paper
- Casey, B. (2021). Gestational diabetes - on broadening the diagnosis. New England Journal of Medicine. https://doi.org/10.1056/nejme2100902
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.